Check out the newest COMBACTE Video!

Watch Video

CLIN-Net maintains an up-to-date portfolio of clinical trial sites across Europe. This maximizes the efficiency of site selection and study performance for studies related to antimicrobial resistance.

CLIN-Net aims to optimize trial logistics with novel antibacterial agents. To this end, we are establishing and maintaining a pan-European network of clinics and hospitals. Capable of quickly and reliably recruiting, treating, monitoring and reporting data on the required numbers of patients in multinational, multicenter trials at all stages of clinical drug development.

High-quality clinical studies

We aim to become a premier Europe-wide network of hospitals prepared for performing high-quality clinical studies with new antimicrobials against multidrug-resistant bacterial pathogens. The ultimate goal is to create a self-sustaining organization active in all European countries.

Good Clinical Practice (GCP)

Clinical sites within CLIN-Net are certified based on training levels of physicians and performance in clinical studies. We provide additional training where required. Read more about GCP-training here.

Key members

  • Amanda de Oude

    Project officer / Academic / UMC Utrecht

  • Claudia Recanatini

    Project officer / Academic / UMC Utrecht

  • Jelle Lyskawa

    Project officer / Academic / UMC Utrecht

  • Karin van Beek

    Project officer / Academic / UMC Utrecht

  • Katina Kardamanidis del

    Project officer / Academic / UMC Utrecht

  • Marc Bonten

    Management board / Academic leader / UMC Utrecht

  • Miquel Ekkelenkamp

    Academic / UMC Utrecht

  • Miranda Hopman

    Project Manager / Academic / UMC Utrecht

  • Nienke Cuperus

    Project officer / Academic / UMC Utrecht

  • Ron de Winter

    Coordinator / Academic / UMC Utrecht

  • Sanne Hofstraat

    Project officer / Academic / UMC Utrecht

  • Seamus O'Brien

    EFPIA leader / Pfizer